lily direct tirzepatide Eli Lilly launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can Eli Lilly's weight loss drug

10.1249/01.MSS.0000069553.47739.36

The addition of glucagon receptor agonism introduces a thermogenic and lipolytic dimension unavailable to dual agonists like Tirzepatide UK or single-target agents like Semaglutide UK

A Phase 2 clinical trial evaluating semaglutide, a related GLP-1 medication , showed robust reductions in alcohol consumption during laboratory-based self-administration tasks

Lars Fruergaard Jrgensen, Novo Nordisks chief executive, said: We are very satisfied with the sales growth in the first nine months of 2023, which is reflecting that more people than ever are benefiting from our innovative diabetes and obesity treatments. Novo is racing to keep up with demand, and said it would restrict supplies of Wegovy in the US

All of the study participants were either overweight or obese but did not have diabetes

Like any surgery, there are some risks involved, but it is usually safe if your doctor has recommended it